Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium for Lung and Diaphragm Protection in Mechanically Ventilated ICU Patients
NCT03646266Phase 4Unknown
- Sponsor
- Amsterdam University Medical Center
- Start
- Aug 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rocuronium in Respiratory Insufficiency (RI), sponsored by Amsterdam University Medical Center. Status: unknown.
02
Drugs
rocuronium
03
Conditions
Respiratory Insufficiency (RI)
Beyond the preview
Go deeper on NCT03646266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03646266.